Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
Titel:
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
Auteur:
Eufemon Cereno, Reno Mou, Benjamin Baker, Sarah Chng, Nick Arbour, Gregory Bergman, Alanah Liu, Mitchell Schellenberg, Devin Matthews, Quinn Huang, Vicky Mestrovic, Ante Hyde, Derek Alexander, Abraham Carolan, Hannah Hsu, Fred Miller, Stacy Atrchian, Siavash Chan, Elisa Ho, Clement Mohamed, Islam Lin, Angela Berrang, Tanya Bang, Andrew Jiang, Will Lund, Chad Pai, Howard Valev, Boris Lefresne, Shilo Tyldesley, Scott Olson, Robert A.